8 Coupons
-
Special Offer
-
30% off
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. here are 4 mass. biotechs making noise at the ash conference so far
.
here are 4 mass. biotechs making noise at the ash conference so far
. copyright © the asahi shimbun company. all rights reserved. no reproduction or republication without written permission.
copyright © the asahi shimbun company. all rights reserved. no reproduction or republication without written permission.